Cargando…
Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension
Invasive bladder tumours express the cell-surface Sialyl-Tn (STn) antigen, which stems from a premature stop in protein O-glycosylation. The STn antigen favours invasion, immune escape, and possibly chemotherapy resistance, making it attractive for target therapeutics. However, the events leading to...
Autores principales: | Peixoto, Andreia, Fernandes, Elisabete, Gaiteiro, Cristiana, Lima, Luís, Azevedo, Rita, Soares, Janine, Cotton, Sofia, Parreira, Beatriz, Neves, Manuel, Amaro, Teresina, Tavares, Ana, Teixeira, Filipe, Palmeira, Carlos, Rangel, Maria, Silva, André M.N., Reis, Celso A., Santos, Lúcio Lara, Oliveira, Maria José, Ferreira, José Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325352/ https://www.ncbi.nlm.nih.gov/pubmed/27542232 http://dx.doi.org/10.18632/oncotarget.11257 |
Ejemplares similares
-
Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours
por: Cotton, Sofia, et al.
Publicado: (2017) -
Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics
por: Costa, Céu, et al.
Publicado: (2015) -
Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells
por: Fernandes, Elisabete, et al.
Publicado: (2020) -
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
por: Azevedo, Rita, et al.
Publicado: (2017) -
Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
por: Peixoto, Andreia, et al.
Publicado: (2021)